Martín-Dávila Pilar, Navas Enrique, Fortún Jesús, Moya Jose Luis, Cobo Javier, Pintado Vicente, Quereda Carmen, Jiménez-Mena Manuel, Moreno Santiago
Department of Infectious Diseases, Hospital Ramón y Cajal, Madrid, Spain.
Am Heart J. 2005 Nov;150(5):1099-106. doi: 10.1016/j.ahj.2005.02.009.
Native valve endocarditis in drug-user patients had a microbiology, a frequency of involvement of different cardiac valves, and a prognosis that differ from those in non-drug users. A retrospective study of native valve endocarditis cases in intravenous drug users diagnosed from 1985 to 1999 in our institution was performed to analyze the inhospital mortality of drug users with native valve endocarditis and to identify factors predictive of mortality.
All patients fulfilled the Duke's criteria for definite or probable endocarditis. Analysis of predictors of inhospital mortality was restricted to right-sided infective endocarditis (IE) with definite diagnosis and echocardiographic data. The following variables were analyzed: sex, HIV serostatus, CD4 cell count < 200/mm3, time of IE diagnosis (before 1993 or after 1993), previous valvulopathy, polymicrobial IE, fungal etiology (mixed or alone), neurological complication, arterial emboli, pulmonary emboli, congestive heart failure, vegetation size (VS) > 2 cm, and inhospital cardiac surgery. Logistic regression was used in a multivariate model to identify factors independently associated with mortality. Adjusted odds ratios (OR) and 95% CIs were examined.
Four hundred ninety-three cases of IE were diagnosed in this period. Two hundred twenty cases of native valve endocarditis in intravenous drug users were identified. Fourteen cases in this group died (6%). Mean time from diagnosis to death was 18.5 +/- 15 days (range, 3-52). Vegetation size was available in 111 cases. Univariate analysis identified the following variables associated with inhospital mortality in right-sided cases: VS > 2 cm and fungal etiology. In multivariate analysis, the variables associated with mortality that achieved statistical significance were size of vegetation > 2 cm (P = .014, OR 10.2, 95% CI 1.6-78.0) and fungal etiology (P = .009, OR 46.2, 95% CI 2.4-1100.9).
The main prognostic factors of inhospital mortality in right-sided IE in drug users in our series were VS > 2 cm and fungal etiology. The role of early surgery in these patients should be reevaluated.
吸毒患者的自体瓣膜心内膜炎在微生物学、不同心脏瓣膜受累频率及预后方面与非吸毒者不同。我们对1985年至1999年在本机构诊断的静脉吸毒者自体瓣膜心内膜炎病例进行了一项回顾性研究,以分析吸毒者自体瓣膜心内膜炎的住院死亡率,并确定预测死亡率的因素。
所有患者均符合杜克大学明确或可能的心内膜炎标准。住院死亡率预测因素的分析仅限于确诊且有超声心动图数据的右侧感染性心内膜炎(IE)。分析了以下变量:性别、HIV血清学状态、CD4细胞计数<200/mm³、IE诊断时间(1993年之前或1993年之后)、既往瓣膜病、多种微生物感染性心内膜炎、真菌病因(混合或单独)、神经系统并发症、动脉栓塞、肺栓塞、充血性心力衰竭、赘生物大小(VS)>2cm以及住院心脏手术。在多变量模型中使用逻辑回归来确定与死亡率独立相关的因素。检查了调整后的比值比(OR)和95%置信区间(CI)。
在此期间共诊断出493例IE。确定了220例静脉吸毒者的自体瓣膜心内膜炎。该组中有14例死亡(6%)。从诊断到死亡的平均时间为18.5±15天(范围3 - 52天)。111例患者有赘生物大小数据。单变量分析确定了右侧病例中与住院死亡率相关的以下变量:VS>2cm和真菌病因。在多变量分析中,与死亡率有统计学意义相关的变量是赘生物大小>2cm(P =.014,OR 10.2,95%CI 1.6 - 78.0)和真菌病因(P =.009,OR 46.2,95%CI 2.4 - 1100.9)。
在我们的系列研究中,吸毒者右侧IE住院死亡率的主要预后因素是VS>2cm和真菌病因。应重新评估早期手术在这些患者中的作用。